Introduction: The present study evaluated the potential benefit of adding cetuximab to
neoadjuvant, adjuvant, or palliative standard therapy for pancreatic cancer. Methods: A …

Introduction: Pancreatic cancer is a highly malignant disease with an increasing incidence.
Most patients with this type of neoplasm present with unresectable tumors at the time of …

Pancreatic cancer is one of the most dismal malignancies. Although its incidence and
prevalence are relatively low, the disease burden is still an important health issue …